Population Council

Knowledge Commons

3-1-2020

The effects of a family planning training on community
pharmacists and patent and proprietary medicine vendors’
knowledge in Nigeria: Preliminary pre and posttest results, the
IntegratE Project
Population Council

Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh
Part of the Health Services Research Commons

How does access to this work benefit you? Let us know!
Recommended Citation
"The effects of a family planning training on community pharmacists and patent and proprietary medicine
vendors’ knowledge in Nigeria: Preliminary pre and posttest results, the IntegratE Project," IntegratE
Project brief. Abuja: Population Council, 2020.

This Brief is brought to you for free and open access by the Population Council.

project brief

The effects of a family planning training on
Community Pharmacists and Patent and Proprietary
Medicine Vendors’ knowledge in Nigeria: Preliminary
pre and posttest results, the IntegratE Project

BACKGROUND
In Nigeria, Community Pharmacists (CPs) and Patent
and Proprietary Medicine Vendors (PPMVs) are the first
point of care for many communities. A CP is a trained
pharmacist with full license to sell and buy prescription
and non-prescription drugs and a PPMV is defined as “a
person without formal training in pharmacy who sells
orthodox pharmaceutical products on a retail basis for
profit”[1]. Many women in Nigeria who use a modern
contraceptive (41%) receive their method from the
private sector [2]. Although CPs and PPMVs are not
formally recognized as family planning (FP) service
providers, they are a popular source for contraception
among both public and private sources with 22% of
modern contraceptive users receiving their last method
from a PPMV and 12 percent receiving their method
from a private pharmacy [2]. PPMVs are especially
popular source for FP due to their widespread
availability, consistent drug stocks, extended hours,
personable interactions, and no separate fees for
consultations [3, 4]. CPs and PPMV, however, have not
received formal training to provide FP services and often
do not have the necessary knowledge and skills to
competently provide these services. Previous studies
have shown that with training, PPMVs can provide
injectable contraceptives [5]. As the Federal Ministry of
Health (FMoH) explores expanding its task sharing policy
to include CPs and PPMVs, evidence is needed on an
effective regulatory system to support PPMVs and CPs
to provide high quality FP services.
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THE INTEGRATE PROJECT
The IntegratE Project is a 4-year initiative (2017-2021)
funded by the Bill & Melinda Gates Foundation and
MSD for Mothers1 that seeks to increase access to
contraceptive methods by involving the private sector
(CPs and PPMVs) in FP service delivery in Lagos and
This programme is co-funded by, developed and is being
implemented in collaboration with MSD for Mothers, MSD’s $500
million initiative to help create a world where no woman dies giving
life. MSD for Mothers is an initiative of Merck & Co., Inc., Kenilworth,
NJ, U.S.A
1
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Kaduna States. IntegratE is implemented by a
consortium of partners, Marie Stopes International,
Planned Parenthood Federation of Nigeria, Population
Council, PharmAccess, and led by the Society for Family
Health. The project seeks to establish a regulatory
system with the Pharmacists Council of Nigeria (PCN) to
ensure that CPs and PPMVs provide quality FP services,
comply with FP regulations and report service statistics
to the Health Information Management System (HMIS).
To achieve this, the IntegratE Project in collaboration
with PCN and the FMoH, is implementing three main
activities: (1) a pilot 3-tiered accreditation system for
PPMVs based on their healthcare qualifications; (2) a
pilot a hub-and-spoke supervisory model to ensure
standard drug stocking practices; and (3) building the
capacity of CPs and PPMVs to provide expanded FP
services and report service statistics to the HMIS. Under
the pilot accreditation system, PPMVs are provided with
a standardized FP training and would provide certain FP
services based on their tier (Table 1). CPs would function
outside of the accreditation system but would receive
the same training and provide the same services as Tier
2 PPMVs. This brief focuses on knowledge results from
before and after the FP training that is part of the pilot
accreditation system. Additional information on
IntegratE
Project
can
be
found
on
www.integrateeproject.org.ng.
Table 1: Description of tier accreditation system
Provider
type

Description

Training received

Tier 1
PPMVs

PPMVs without
healthcare
qualifications
PPMVs with
healthcare
qualifications
PPMVs who are also
pharmacy
technicians
Outside of
accreditation system

• FP counseling and referral
• Refill of oral contraceptives

Tier 2
PPMVs
Tier 3
PPMVs
CPs

•
•
•
•
•
•
•
•
•

FP counseling and referral
Injectable administration
Implant insertion and removal
FP counseling and referral
Injectable administration
Implant insertion and removal
FP counseling and referral
Injectable administration
Implant insertion and removal

ASSESSING PPMV AND CP
KNOWLEDGE TO PROVIDE FAMILY
PLANNING SERVICES
The IntegratE project is conducting a mixed-methods on
CPs and PPMVs’ capacity to provide high quality FP
services. Starting in January 2019, 430 CPs and PPMVs
from Kaduna and Lagos states trained by the IntegratE
project were enrolled into the study2. As part of the
study, enrolled CPs and PPMVs completed a selfadministered questionnaire to assess their knowledge
related to the provision of FP counseling, and injectable
and implant contraceptive services immediately before
and after the training. Additional knowledge
assessments will be conducted 9-27 months after their
initial training. Preliminary results from the pre and
posttest questionnaires are presented in this brief.

RESULTS

higher at posttest than at pretest, although knowledge
remained low for some questions. At posttest, almost all
(97% in Kaduna and 99% in Lagos) correctly answered
that condoms are the only method that prevents both
pregnancy and HIV and a majority correctly answered
that the client is the most appropriate person to choose
which FP method to use rather than the provider or her
husband (87% in Kaduna and 86% in Lagos). At
posttest, fewer (59% in Kaduna and 66%) in Lagos
answered that if a client experiences a sudden change
in health (other than a normal side effect of the method),
she should be advised to go to the nearest health facility
and inform them of the method she is using. Less than
half of respondents in Kaduna (47%) and two-thirds in
Lagos (66%) correctly identified Copper IUD as a nonhormonal method at posttest.

At least 79% of CPs and Tier 2 PPMVs
correctly answered Depo-Provera and
Sayana Press questions at posttest.
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PPMV and CP characteristics
In both states, over half of PPMVs and CPs were female
(54% in Kaduna and 58% in Lagos) and 35 years old and
older (56% in Kaduna and 71% in Lagos; see Table 2).
The majority were married (79% in Kaduna and 83% in
Lagos) and approximately three-quarters had attained
two or more years of post-secondary education (71% in
Kaduna and 75% in Lagos). In Kaduna, 51% were Tier 2
PPMVs, 39% were CPs, and 10% were Tier 1 PPMVs. In
Lagos, two-thirds were CPs (67%), 24% were Tier 1
PPMVs and 9% were Tier 2 PPMVs.

CP and Tier 2 PPMV knowledge of
injectable contraceptives

98% OF RESPONDENTS IN BOTH STATES
KNEW CONDOMS PREVENT PREGNANCY
AND STI AT POSTTEST

Sex*
Male
Female
Age*
20-34

PPMV and CP general FP counseling
knowledge

35+
56.2
71.2
63.0
Marital Status*
Single
16.3
13.2
14.9
Married/ In-union
79.4
83.3
81.2
Widowed/divorced
3.4
3.1
3.3
Highest level of education achieved*
Primary
0.9
0.5
0.7
Secondary
6.4
16.8
11.2
2+ years post70.8
75.1
72.8
secondary
Other professional
15.0
4.1
10.0
certificate
Cadre
Tier 1 PPMV
10.3
23.9
16.5
Tier 2 PPMV
50.6
9.1
31.6
CP
39.1
67.0
51.9
*Totals do not equal 100 due to missing observations

All enrolled CPs and PPMVs, regardless of tier, were
trained to provide quality FP counseling. The training
included: (a) information on the different contraceptive
methods available in Nigeria; (b) instruction and
practice sessions on providing client-centered FP
counseling using the Balance Counseling Strategy
toolkit; and (c) instruction on how and when to refer
clients to other sources of care based on the methods
CPs and PPMVs are authorized to provide and the
client’s medical eligibility. Figure 1 shows the proportion
of respondents who correctly answered key FP
questions at pretest and posttest. Knowledge was
All participants enrolled in the study were given detailed
information about the study before consenting to participate.
2
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CPs and Tier 2 PPMVs (n=359) were given information
on
injectable
contraceptives
and
practiced
administering injectables, including Depo-Provera and
Table 2: PPMV and CP characteristics
Kaduna
Lagos
(n=233)
(n=197)

Total
(N=430)

44.6
54.1

41.6
58.4

43.3
56.1

39.5

25.4

33.0

Figure 1: CP and PPMV knowledge of FP counseling on the self-administered pretest and posttest (n=430)
97.4 94.4 98.5
92.3

100

86.7

75

65.0
47.2

50
33.9

85.8

60.9

67.0
65.5

58.8
52.8

40.6

37.6

25

0
Kaduna
(n=233)

Lagos
(n=197)

Condoms prevent
both pregnancy and
HIV

Kaduna
(n=233)

Lagos
(n=197)

Kaduna
(n=233)

Lagos
(n=197)

Kaduna
(n=233)

Lagos
(n=197)

Copper IUD is not a
The client should
Client should go to
hormonal
choose which method health facility/inform
contraceptive
to use
them of the method
she uses if health
changes
Pre-test
Posttest

Sayana Press, on dummy models and in a clinical setting
during the training. Knowledge was generally higher at
posttest, especially for questions about Sayana Press,
than at pretest. At posttest, most respondents in
Kaduna (83%) and Lagos (91%) identified that DepoProvera is administered intramuscularly, and that it is
administered every three months (87% in Kaduna and
94% in Lagos). Almost all respondents in Lagos (97%)
and 79% in Kaduna knew that Sayana Press is

administered subcutaneously,
and over 80% in each state
knew that it is administered
every three months (80% in
Kaduna and 83% in Lagos).
Many (87% in Kaduna and
89% in Lagos) correctly
identified that Depo-Provera
and Sayana Press have the
same active drug and are
equally effective at preventing
pregnancy. Few, however,
correctly answered that the
content of sharps boxes
should be disposed of at a
health facility at posttest
(Kaduna 24% and 47% in
Lagos). The most common
response at posttest was that
sharps should be buried in the
ground (approximately 51% of
all respondents, data not
shown).

Tier 2 PPMV and CP knowledge of
contraceptive implants
CPs and Tier 2 PPMVs were given information on, and
practiced inserting, contraceptive implants during their
training. They were also asked questions about
knowledge before and after the training. Across both
states and for all key indicators shown, implant
knowledge was higher at posttest than at the pretest

Figure 2: CP and Tier 2 PPMV knowledge of injectable contraceptives, self-administered pretest and posttest (n=359)
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Kaduna Lagos Kaduna Lagos Kaduna Lagos Kaduna Lagos Kaduna Lagos Kaduna Lagos
(n=209) (n=150) (n=209) (n=150) (n=209) (n=150) (n=209) (n=150) (n=209) (n=150) (n=209) (n=150)
Depo-Provera
Depo-Provera
administered route injection frequency
(IM)
(3 months)

Sayana Press
administration
route (SC)
Pre-test
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Sayana Press
Depo-Provera &
Sharps should be
injection frequency
Sayana Press
disposed of at a
(3 months)
contain the same
health facility
drug that prevents
Post-test
pregnancy

(Figure 3). For example, over three-quarters of CPs and
Tier 2 PPMVs in each state knew that the Nexplanon
implant is effective for three years at posttest (76% in
Kaduna and 78% in Lagos). Most (88% in Kaduna and
95% in Lagos 95%) knew that the implant is inserted
under the skin of the arm. Fewer correctly identified the
angle at which Nexplanon must be inserted: 37% in
Kaduna and 49% in Lagos. At posttest, just over half of
respondents in Kaduna (53%) and two-thirds in Lagos
(67%) knew that implants inserted into the fat under the
skin may be more difficult to remove.

CONCLUSION
Preliminary results from the pretest and posttest are
promising and suggest that PPMVs and CPs can be
trained on general FP counseling using a standardized
training curriculum. Additional attention is needed to
improve knowledge of non-hormonal methods, such as
the copper IUD, and how to counsel clients if they
experience a sudden change in their health. Results also
suggest that trainings should focus additional attention
on how and where to dispose of sharps, and of the angle
at which Nexplanon must be inserted. The role of job
aids to reinforce knowledge will also be explored as
demonstrated by a previous study [6]. Overall, results
are promising for expanding the role of CPs and PPMVs
service delivery in Nigeria.

The proportion of CPs and Tier 2 PPMVs
who correctly answered these 4 implant
questions was higher at posttest than
pre-test

Figure 3: CP and Tier 2 PPMV knowledge of contraceptive implants at the self-administered pre-test and posttest (n=359)
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